In addition to being linked to an increased mitotic rate, advanced tumour grade, and metastasis, IL-19 expression in BC tissue is also predicted to be worse for MFS and DSS with a risk that is more than three times higher (Esquivel-Velázquez et al., 2015). Here, IL19 is linked to breast cancer.